UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

JAMA : the journal of the American Medical Association, 2021-12, Vol.326 (21), p.2203

2021

Volltextzugriff (PDF)

The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

Cell, 2014-07, Vol.158 (3), p.564-578

2014

Volltextzugriff (PDF)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

Breast (Edinburgh), 2021-12, Vol.60, p.62-69

2021

Volltextzugriff (PDF)

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

JAMA oncology, 2021-08, Vol.7 (8), p.1133

2021

Volltextzugriff (PDF)

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

PLoS genetics, 2019-06, Vol.15 (6), p.e1008181

2019

Volltextzugriff (PDF)

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment

JAMA oncology, 2021-11, Vol.7 (11), p.1716

2021

Volltextzugriff (PDF)

Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles

Cancer research (Chicago, Ill.), 2021-04, Vol.81 (7), p.1639-1653

2021

Volltextzugriff (PDF)

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer

Journal of clinical oncology, 2013-07, Vol.31 (20), p.2586-2592

2013

Volltextzugriff (PDF)

In vivo bioimaging as a novel strategy to detect doxorubicin-induced damage to gonadal blood vessels

PloS one, 2011-09, Vol.6 (9), p.e23492-e23492

2011

Volltextzugriff (PDF)

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

Journal of cachexia, sarcopenia and muscle, 2018-10, Vol.9 (5), p.871-879

2018

Volltextzugriff (PDF)

Anti-Müllerian Hormone Is a Marker for Chemotherapy-Induced Testicular Toxicity

Endocrinology (Philadelphia), 2015-10, Vol.156 (10), p.3818-3827

2015

Volltextzugriff (PDF)

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

Nature communications, 2023-02, Vol.14 (1), p.630-630, Article 630

2023

Volltextzugriff (PDF)

Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis

PloS one, 2013-08, Vol.8 (8), p.e70044-e70044

2013

Volltextzugriff (PDF)

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

JAMA network open, 2022-07, Vol.5 (7), p.e2223090-e2223090

2022

Volltextzugriff (PDF)

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2212-2217

2007

Volltextzugriff (PDF)

Proteinoid Polymers and Nanocapsules for Cancer Diagnostics, Therapy and Theranostics: In Vitro and In Vivo Studies

Journal of functional biomaterials, 2023-04, Vol.14 (4), p.215

2023

Volltextzugriff (PDF)

Doxorubicin-induced ovarian toxicity

Reproductive biology and endocrinology, 2010-03, Vol.8 (1), p.20-20, Article 20

2010

Volltextzugriff (PDF)

Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy

Pharmaceuticals (Basel, Switzerland), 2021-07, Vol.14 (7), p.648

2021

Volltextzugriff (PDF)

Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects

Journal of traumatic stress, 2015-06, Vol.28 (3), p.214-222

2015

Volltextzugriff (PDF)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Radiation oncology (London, England), 2017-10, Vol.12 (1), p.163-163, Article 163

2017

Volltextzugriff (PDF)

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

The lancet oncology, 2013-02, Vol.14 (2), p.125-133

2013

Volltextzugriff (PDF)

Interventions for Alleviating Cancer-Related Dyspnea: A Systematic Review

Journal of clinical oncology, 2008-05, Vol.26 (14), p.2396-2404

2008

Volltextzugriff (PDF)

miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines

Frontiers in oncology, 2020-02, Vol.10, p.191-191

2020

Volltextzugriff (PDF)

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study

BMJ open, 2022-08, Vol.12 (8), p.e061584-e061584

2022

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(220)

Publikationsform

Artikel
(240)

Sprache

Englisch
(240)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Humans
(112)
Life Sciences & Biomedicine
(109)
Oncology
(89)
Female
(85)
Middle Aged
(61)
Aged
(53)
Adult
(49)
Chemotherapy
(48)
Male
(48)
Cancer Therapies
(47)
Breast Cancer
(46)
Patients
(40)
Cancer
(39)
Tumors
(39)
Multidisciplinary Sciences
(32)
Science & Technology - Other Topics
(32)
Breast Neoplasms - Drug Therapy
(29)
Medicine
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(64)
Plos One
(37)
Cancer Research
(13)
Breast Cancer Research And Treatment
(7)
Npj Breast Cancer
(5)
The Oncologist
(4)
The oncologist
(4)
American Journal Of Clinical Oncology
(3)
Cancers
(3)
Jama Oncology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibody Titers Before and After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in Adults Aged ≥60 Years

The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals

Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment

Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles

Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer

In vivo bioimaging as a novel strategy to detect doxorubicin-induced damage to gonadal blood vessels

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial

Anti-Müllerian Hormone Is a Marker for Chemotherapy-Induced Testicular Toxicity

Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers

Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis

Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults

Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Proteinoid Polymers and Nanocapsules for Cancer Diagnostics, Therapy and Theranostics: In Vitro and In Vivo Studies

Doxorubicin-induced ovarian toxicity

Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy

Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial

Interventions for Alleviating Cancer-Related Dyspnea: A Systematic Review

miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines

Three-month follow-up of durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: a prospective cohort study

Suchergebnisse filtern